2D Ultrathin MXene‐Based Drug‐Delivery Nanoplatform for Synergistic Photothermal Ablation and Chemotherapy of Cancer

  • Xiaoxia Han
    Second Affiliated Hospital Institute of Ultrasound Imaging Chongqing Medical University Chongqing 400010 P. R. China
  • Ju Huang
    Second Affiliated Hospital Institute of Ultrasound Imaging Chongqing Medical University Chongqing 400010 P. R. China
  • Han Lin
    State Key Laboratory of High Performance Ceramics and Superfine Microstructure Shanghai Institute of Ceramics Chinese Academy of Sciences Shanghai 200050 P. R. China
  • Zhigang Wang
    Second Affiliated Hospital Institute of Ultrasound Imaging Chongqing Medical University Chongqing 400010 P. R. China
  • Pan Li
    Second Affiliated Hospital Institute of Ultrasound Imaging Chongqing Medical University Chongqing 400010 P. R. China
  • Yu Chen
    State Key Laboratory of High Performance Ceramics and Superfine Microstructure Shanghai Institute of Ceramics Chinese Academy of Sciences Shanghai 200050 P. R. China

書誌事項

公開日
2018-02-05
権利情報
  • http://onlinelibrary.wiley.com/termsAndConditions#vor
DOI
  • 10.1002/adhm.201701394
公開者
Wiley

この論文をさがす

説明

<jats:title>Abstract</jats:title><jats:p>Two‐dimensional (2D) MXenes, as a new 2D functional material nanosystem, have been extensively explored for broad applications. However, their specific performance and applications in theranostic nanomedicine have still rarely been explored. This work reports on the drug‐delivery performance and synergistic therapeutic efficiency of Ti<jats:sub>3</jats:sub>C<jats:sub>2</jats:sub> MXenes for highly efficient tumor eradication. These Ti<jats:sub>3</jats:sub>C<jats:sub>2</jats:sub> MXenes not only possess high drug‐loading capability of as high as 211.8%, but also exhibit both pH‐responsive and near infrared laser‐triggered on‐demand drug release. Especially, based on the high photothermal‐conversion capability of Ti<jats:sub>3</jats:sub>C<jats:sub>2</jats:sub> MXenes, they have been further explored for efficient tumor eradication by synergistic photothermal ablation and chemotherapy, which has been systematically demonstrated both in vitro and in vivo. These Ti<jats:sub>3</jats:sub>C<jats:sub>2</jats:sub> MXenes have also been demonstrated as the desirable contrast agents for photoacoustic imaging, showing the potential for diagnostic‐imaging guidance and monitoring during therapy. The high in vivo histocompatibility of Ti<jats:sub>3</jats:sub>C<jats:sub>2</jats:sub> and their easy excretion out of the body have been evaluated and demonstrated, showing the potential high biosafety for further clinical translation. This work paves a new way for broadening biomedical applications of MXenes in nanomedicine where they can exert the high performance and functionality for synergistic therapy, especially on combating cancer.</jats:p>

収録刊行物

被引用文献 (1)*注記

もっと見る

問題の指摘

ページトップへ